Segmental bile duct resection versus pancreatoduodenectomy for middle and distal third bile duct cancer. A systematic review and meta-analysis of comparative studies
HPB · 2023
DOI: 10.1016/j.hpb.2023.06.012 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift HPB, 2023. Verfasst von Andrew M Fleming und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN, USA. Electronic address: aflemin8@uthsc.edu. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Biliary Tract Surgical Procedures, Pancreaticoduodenectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Data regarding oncologic outcomes of segmental bile duct resection (SBDR) versus pancreatoduodenectomy (PD) for bile duct cancers (BDC) are conflicting. We compared SBDR and PD for BDC utilizing pooled data analysis. MATERIALS AND METHODS: A comprehensive PRISMA 2020 systematic review was performed. Studies comparing SBDR with PD for BDC were included. Pooled mean differences (MD), odds ratios (OR), and risk ratios (RR) with 95% confidence intervals (CI) were calculated. Subgroup analyses were performed. Study quality, bias, heterogeneity, and certainty were analyzed. RESULTS: Twelve studies from 2004 to 2021 were included, comprising 533 SBDR and 1,313 PD. SBDR was associated with positive proximal duct margins (OR 1.56; CI 1.11-2.18; P = .01), and distal duct margins (OR 43.25; CI 10.38-180.16; P < .01). SBDR yielded fewer lymph nodes (MD -6.93 nodes; CI -9.72-4.15; P < .01) and detected fewer nodal metastases (OR 0.72; CI 0.55-0.94; P = .01). SBDR portended less perioperative morbidity (OR 0.31; CI 0.21-0.46; P < .01), but not mortality (OR 0.52; CI 0.20-1.32; P = .17). SBDR was associated with locoregional recurrences (OR 1.88; CI 1.01-3.53; P = .02), and lymph node recurrences (OR 2.13; CI 1.42-3.2; P = .04). SBDR yielded decreased 5-year OS (OR 0.75; CI 0.65-0.85; P < .01). CONCLUSIONS: Despite decreased perioperative morbidity, SBDR appears to provide inferior oncologic control for BDC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN, USA. Electronic address: aflemin8@uthsc.edu.
- College of Medicine, The University of Tennessee Health Science Center, Memphis, TN, USA.
- Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN, USA.
- Division of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
- Division of Surgical Oncology, The University of Tennessee Health Science Center, Memphis, TN, USA.
- Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, Rochester MN, USA.
Zitieren
APA
Fleming, A. M., Phillips, A. L., Hendrick, L. E., Drake, J. A., Dickson, P. V., Glazer, E. S., Shibata, D., Cleary, S. P., Yakoub, D., & Deneve, J. L. (2023). Segmental bile duct resection versus pancreatoduodenectomy for middle and distal third bile duct cancer. A systematic review and meta-analysis of comparative studies. HPB. https://doi.org/10.1016/j.hpb.2023.06.012
Vancouver
Fleming AM, Phillips AL, Hendrick LE, Drake JA, Dickson PV, Glazer ES, et al. Segmental bile duct resection versus pancreatoduodenectomy for middle and distal third bile duct cancer. A systematic review and meta-analysis of comparative studies. HPB. 2023. doi:10.1016/j.hpb.2023.06.012
BibTeX
@article{Fleming2023,
author = {Fleming, Andrew M and Phillips, Alisa L and Hendrick, Leah E and Drake, Justin A and Dickson, Paxton V and Glazer, Evan S and Shibata, David and Cleary, Sean P and Yakoub, Danny and Deneve, Jeremiah L},
title = {Segmental bile duct resection versus pancreatoduodenectomy for middle and distal third bile duct cancer. A systematic review and meta-analysis of comparative studies},
journal = {HPB},
year = {2023},
doi = {10.1016/j.hpb.2023.06.012}
}
EUVIMED